I'm disappointed to see that Intel bought into (and encouraged) all of this media hype over something that, while remarkable given his age, has yet to demonstrate itself to be any sort of a game-changer. The statistics quoted at the end ("168 times faster, 400 times more sensitive, and 26,000 times less expensive than the medical standard") are at best extremely misleading and at worst simply not true. Furthermore, they ignore the fact that it has yet to be demonstrated that this test is even reliable (let alone practical). Indeed, previous research suggests that the method he's using could lead to significant false positives.
The work will deserve serious accolades when, and only when, it has actually demonstrated real advances in treatment, or at the very least been published in a peer-reviewed journal. Not theoretical "this is how it could be, assuming X, Y, and Z; and ignoring W".
Cancer is an incredibly difficult field; it deserves a higher level of intellectual integrity and adherence to rigor than what Intel has demonstrated thus far.